Age-associated increase in cleaved caspase 3 despite phosphorylation of IGF-1 receptor in the rat retina.
Diseases of aging produce many alterations in the retina, but changes in growth factor signaling in normal aging are less characterized. This study investigated modifications in insulin-like growth factor-1 (IGF-1) receptor (IGF-1R) signaling in the retina of Brown Norway x Fischer 344 F1 hybrid rats at 8, 22, and 32 months. Immunoblotting for proteins involved in IGF-1R signal transduction and electroretinograms were done to evaluate changes with aging. Aging produced a significant decrease in b-wave and oscillatory potential amplitudes in the retina. Aging produced increased phosphorylation of IGF-1R. Despite the increase in IGF-1R activity, insulin receptor substrate-1 (IRS-1) phosphorylation was significantly decreased with increasing age. Akt activity was significantly decreased at 22 and 32 months of age, resulting in increased cleaved caspase 3 levels. The results suggest that regulation of IRS-1 phosphorylation may modulate apoptotic rates in the aging retina, potentially preventing activation of vascular endothelial cell growth factor.
Jiang
Youde
Y
Department of Ophthalmology, Hamilton Eye Institute, University of Tennessee Health Science Center, Memphis, TN, USA.
Walker
Robert J
RJ
Steinle
Jena J
JJ
D000375:Aging / Q000378:metabolism*; D000818:Animals; D053148:Caspase 3 / Q000378:metabolism*; D004596:Electroretinography; D055504:Insulin Receptor Substrate Proteins / Q000378:metabolism; D008297:Male; D010766:Phosphorylation; D051381:Rats; D011914:Rats, Inbred BN; D011916:Rats, Inbred F344; D017526:Receptor, IGF Type 1 / Q000378:metabolism*; D012160:Retina / Q000378:metabolism*
D055504:Insulin Receptor Substrate Proteins; C526296:Irs1 protein, rat; C526299:Irs2 protein, rat; D017526:Receptor, IGF Type 1; D053148:Caspase 3
J Gerontol A Biol Sci Med Sci. 2009 Mar;64(3):325-31
19181710
Biol Neonate. 2005;88(3):237-44
16210846
Aging Cell. 2008 Jun;7(3):285-90
18346217
Curr Eye Res. 1995 Apr;14(4):303-10
7606916
Exp Eye Res. 2007 Jan;84(1):118-25
17067575
Am J Pathol. 2007 Jul;171(1):53-67
17591953
J Biol Chem. 1997 Nov 21;272(47):29911-8
9368067
Surv Ophthalmol. 2000 Sep-Oct;45(2):115-34
11033038
J Biol Chem. 2002 Mar 15;277(11):8961-9
11779863
J Biol Chem. 1997 Jan 10;272(2):971-6
8995390
Invest Ophthalmol Vis Sci. 1993 Nov;34(12):3278-96
8225863
J Neurosci Methods. 2008 Mar 30;169(1):191-200
18243330
Prog Retin Eye Res. 2008 Jan;27(1):1-44
18042420
Endocrinology. 2007 Feb;148(2):594-608
17068137
J Diabetes Complications. 2006 May-Jun;20(3):196-204
16632241
Endocrinology. 2002 Oct;143(10):4139-42
12239127
Biol Rev Camb Philos Soc. 2004 May;79(2):235-51
15191224
Exp Gerontol. 2003 Oct;38(10):1041-9
14580857
PLoS One. 2008;3(11):e3554
18978936
Immunol Cell Biol. 2005 Dec;83(6):651-67
16266318
Neurochem Int. 2007 Apr;50(5):749-56
17363112
J Intern Med. 1999 Jun;245(6):621-5
10395191
Cell. 2005 Feb 25;120(4):449-60
15734678
Prog Retin Eye Res. 2006 May;25(3):249-76
16580242
J Gerontol. 1994 Jan;49(1):B1-11
8282970
J Biol Chem. 2000 Mar 24;275(12):9047-54
10722755
Cell Immunol. 2008 Mar-Apr;252(1-2):91-110
18325486
Glia. 2007 Aug 15;55(11):1099-107
17577243
Exp Eye Res. 2007 Dec;85(6):817-24
17936752
Invest Ophthalmol Vis Sci. 1992 Jan;33(1):1-17
1730530
Curr Diabetes Rev. 2006 Feb;2(1):71-98
18220619
J Neurochem. 2001 May;77(4):1157-67
11359881
Eur J Endocrinol. 2004 Aug;151 Suppl 1:S23-7
15339240
J Clin Invest. 2003 Jun;111(12):1835-42
12813019
Exp Eye Res. 2007 Jan;84(1):75-81
17074321
Am J Physiol Endocrinol Metab. 2002 Sep;283(3):E413-22
12169433